CIENCIASMEDICASNEWS: Cancers of the Head & Neck

sábado, 23 de septiembre de 2017

Cancers of the Head & Neck | Home

Cancers of the Head & Neck

Head & Neck Cancer Symposium, September 2017

Boston University School of Medicine proudly presents

‘Advances in Head and Neck Cancer: Immunotherapy and Precision Medicine’

25th September 2017, Boston University, Massachusetts, USA

Please click here for details about the symposium, registration information (Early Bird Registration is available until 11thAugust 2017) and details on abstract submission.

Featured article: 'Indolent thyroid cancer: knowns and unknowns'

Advances in the enhanced detection and diagnosis of thyroid cancer have subsequently caused its incidence to rapidly increase. Whilst this undoubtedly will have a positive impact for the detection of malignancies, these advances also mean that indolent tumors (those which do not adversely impact a patient’s life span) are also being detected. Since surgical and radiological intervention of indolent tumors can cause more harm to the patient than good, there is a need to develop clinical management strategies for indolent tumors to help identify the most appropriate treatment options, if any, taking into account quality of life and cost implications.

In this review, L.D. Hahn et al., discuss the studies that have begun to distinguish indolent thyroid cancer from more aggressive forms to ultimately prevent an epidemic of overtreatment.

Click here to access the full article.

Aims and scope

Cancers of the Head & Neck is an open access, peer-reviewed journal dedicated to publishing articles on pre-clinical and translational research, as well as research related to the clinical management of head and neck cancers. This includes cancers of the oral cavity, pharynx, larynx, paranasal sinuses, nasal cavity and salivary glands. Articles related to the etiology, pathophysiology, prevention, diagnosis, treatment and survivorship of these cancers are all considered.